BREAKING
Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 2 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 3 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 6 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 8 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 9 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 12 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 13 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 14 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 15 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 16 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 2 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 3 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 6 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 8 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 9 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 12 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 13 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 14 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 15 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 16 hours ago
ADVERTISEMENT
Market News

Landec posts wider-than-expected loss in Q2

Landec Corporation (LNDC) slipped to a loss in the second quarter from a profit last year, due to acquisition-related expenses, higher operating expenses, the lower fair market value of its Windset investment, and an increase in interest expense. The results missed analysts’ expectations. The company lowered its earnings outlook for fiscal 2019 due to accounting […]

January 3, 2019 2 min read

Landec Corporation (LNDC) slipped to a loss in the second quarter from a profit last year, due to acquisition-related expenses, higher operating expenses, the lower fair market value of its Windset investment, and an increase in interest expense. The results missed analysts’ expectations. The company lowered its earnings outlook for fiscal 2019 due to accounting for the projected loss from the acquisition of Yucatan.

Net loss was $584 million or $0.02 per share compared to a profit of $487 million or $0.02 per share in the previous year quarter.

Product sales rose by 2% to $124.9 million. This was primarily due to a 9% jump in revenues at Lifecore and a 1% rise in Landec Natural Foods revenues.

Looking ahead into fiscal 2019, the company lifted its revenue growth outlook to the range of 6% to 8% from the prior range of 5% to 7%, due to the projected revenues from Yucatan during the second half. Earnings guidance are lowered to the range of $0.25 to $0.29 per share from the prior range of $0.45 to $0.50 per share.

Landec Q1 profit dips 91%, yet tops estimates

ADVERTISEMENT

For fiscal 2019, Landec expects Lifecore to grow 14% to 16% range and Landec Natural Foods to grow of 5% to 7%. Cash flow from operations is anticipated to be in the $26 million to $30 million range and capital expenditures are likely to be $40 million to $45 million range.

For the third quarter, the company predicts revenues in the range of $156 million to $159 million and earnings in the range of $0.03 to $0.04 per share. The bottom line forecast reflects acquisition-related costs, additional interest expense, lower gross profit on acquired inventory from the Yucatan acquisition and integration-related expenses.

Landec currently has about $145 million of debt which translates into debt to equity ratio of about 0.57 and debt to tangible assets ratio of 0.43. The company expects leverage ratio to decline and borrowing capacity to increase by fiscal 2019 year-end as the majority of its cash flow from operations are generated in the third and fourth quarters.

Shares of Landec ended Thursday’s regular session down 3.39% at $11.41 on the Nasdaq. Following the earnings release, the stock plunged over 7% in the after-market session.

ADVERTISEMENT

 

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text.

ADVERTISEMENT